Hong Christopher S, Jin Lan, David Wyatt B, Shear Brian, Zhao Amy Y, Zhang Yawei, Erson-Omay E Zeynep, Fulbright Robert K, Huttner Anita, Kveton John, Moliterno Jennifer
Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States.
Department of Surgery, Yale School of Medicine, New Haven, Connecticut, United States.
J Neurol Surg B Skull Base. 2021 Jul;82(Suppl 3):e22-e32. doi: 10.1055/s-0040-1701676. Epub 2020 Mar 16.
Spontaneous hemorrhage into vestibular schwannomas (VSs) is rare and can render more rapid symptom onset and a seemingly poorer prognosis for an otherwise benign pathology. We describe our series of hemorrhagic VS (HVSs) and systematically reviewed the literature to better understand relevant clinical factors and outcomes. Retrospective case review series and systematic review of the literature using PRISMA guidelines. Fifty-three patients with HVS met inclusion criteria. Compared with historical data for all VS, patients with HVS had relatively higher rates of perioperative mortality, significant preoperative facial weakness, and harbored relatively larger tumors. Regardless of the extent of resection (EOR), surgery for HVS resulted in significant improvement of facial weakness ( = 0.041), facial numbness ( < 0.001), vertigo ( < 0.001), and headache ( < 0.001). Patients with facial weakness tended to have larger tumors ( = 0.058) on average and demonstrated significant improvement after surgery, irrespective of EOR ( < 0.01). The use of blood-thinning medications did not affect patient health outcome. Histopathology of HVS samples showed an increased number of dilated/ectatic thin-walled vascular channels, reflective of potentially increased vascular permeability and hypervascularity. HVS may be an aggressive subgroup of VS, associated with a surprisingly high mortality rate. When features of HVS are identified on imaging, these patients should be treated expeditiously, especially given that facial nerve dysfunction, which is identified in more than half of patients with HVS, appears to be reversible. Overall, this study has significant implications in the management of VS, raising awareness of a small, but highly morbid subgroup.
前庭神经鞘瘤(VS)的自发性出血很少见,可导致症状更快出现,对于这种原本良性的病变,其预后似乎更差。我们描述了我们的一系列出血性VS(HVS)病例,并系统回顾了文献,以更好地了解相关临床因素和预后。
回顾性病例系列研究及使用PRISMA指南对文献进行系统回顾。
53例HVS患者符合纳入标准。与所有VS的历史数据相比,HVS患者围手术期死亡率相对较高,术前面神经麻痹明显,且肿瘤相对较大。无论切除范围(EOR)如何,HVS手术均使面神经麻痹(P = 0.041)、面部麻木(P < 0.001)、眩晕(P < 0.001)和头痛(P < 0.001)有显著改善。面神经麻痹患者平均肿瘤往往较大(P = 0.058),且手术后无论EOR如何均有显著改善(P < 0.01)。使用血液稀释药物不影响患者健康结局。HVS样本的组织病理学显示扩张/扩张的薄壁血管通道数量增加,反映出潜在的血管通透性增加和血管增生。
HVS可能是VS的一个侵袭性亚组,死亡率惊人地高。当影像学检查发现HVS特征时,应迅速对这些患者进行治疗,特别是鉴于超过一半的HVS患者存在的面神经功能障碍似乎是可逆的。总体而言,本研究对VS的管理具有重要意义,提高了对一个虽小但致病率高的亚组的认识。